Contextualising the developability risk of antibodies with lambda light chains using enhanced therapeutic antibody profiling
Abstract Antibodies with lambda light chains (λ-antibodies) are generally considered to be less developable than those with kappa light chains (κ-antibodies). Though this hypothesis has not been formally established, it has led to substantial systematic biases in drug discovery pipelines and thus co...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-01-01
|
Series: | Communications Biology |
Online Access: | https://doi.org/10.1038/s42003-023-05744-8 |